Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty
Key facts
- Who runs it
- Poznan University of Medical Sciences
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 90 people enrolled
- Started
- 13 Sept 2025
- Ended
- 25 Mar 2026
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- NaCl 0.9%
- Dexamethasone 4mg
- Record updated
- 22 May 2026
Who can take part
- Age
- 65 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- patients scheduled for total knee arthroplasty
- patients aged >65 and <100 years
- patients can provide informed consent
- patients can reliably report symptoms to the research team
Who cannot take part
- inability to provide first-party consent due to cognitive impairment or a
- infection at the site of the regional block,
- coagulation disorders,
- history of regular steroid medication
- language barrier
- immunodeficiency,
- American Society of Anesthesiologists (ASA) physical status of IV or higher,
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
"The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in iPACK With ACB for Total Knee Arthroplasty" - written in plain language according to ClinicalTrials.gov standards:
Read full original descriptionShow less
The goal of this clinical trial is to learn how the route of dexamethasone administration (either through the vein or nerve block) affects pain and inflammation in people having total knee replacement surgery. All participants will receive two types of nerve blocks before surgery: an iPACK block and an adductor canal block (ACB), which help control pain after the operation.
The main questions the study aims to answer are:
Does injecting dexamethasone into the nerve block reduce pain more effectively than giving it by vein? Which method leads to a lower inflammatory response after surgery? Researchers will compare the two groups to see which route offers better pain relief and less swelling after knee surgery.
Participants will:
Be randomly assigned to receive dexamethasone either in the nerve block or by IV Receive standard care for total knee replacement Rate their pain and have blood tests after surgery to measure inflammation
The 3 groups in the trial
- ControlPlacebo, for comparison
iPACK block with ACB
Treatment: NaCl 0.9%
- iv DEXExisting treatment, for comparison
iPACK block with ACB + iv Dexamethasone
Treatment: Dexamethasone 4mg
- pn DEXExisting treatment, for comparison
iPACK block with ACB + perineural Dexamethasone
Treatment: Dexamethasone 4mg
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Route of Dexamethasone Administration in iPACK and ACB for Total Knee Replacement: A Randomized Trial
- Record updated
- 22 May 2026